Literature DB >> 24361497

CD4+ T cells and IFN-γ are required for the development of Pneumocystis-associated pulmonary hypertension.

Steve D Swain1, Dan W Siemsen2, Rebecca R Pullen2, Soo Han2.   

Abstract

Pulmonary hypertension (PH) is a disease of diverse etiology. Although primary PH can develop in the absence of prior disease, PH more commonly develops in conjunction with other pulmonary pathologies. We previously reported a mouse model in which PH occurs as a sequela of Pneumocystis infection in the context of transient CD4 depletion. Here, we report that instead of the expected Th2 pathways, the Th1 cytokine IFN-γ is essential for the development of PH, as wild-type mice developed PH but IFN-γ knockout mice did not. Because gene expression analysis showed few strain differences that were not immune-function related, we focused on those responses as potential pathologic mechanisms. In addition to dependence on IFN-γ, we found that when CD4 cells were continuously depleted, but infection was limited by antibiotic treatment, PH did not occur, confirming that CD4 T cells are required for PH development. Also, although CD8 T-cells are implicated in the pathology of Pneumocystis pneumonia, they did not have a role in the onset of PH. Finally, we found differences in immune cell phenotypes that correlated with PH, including elevated CD204 expression in lung CD11c(+) cells, but their role remains unclear. Overall, we demonstrate that a transient, localized, immune response requiring IFN-γ and CD4-T cells can disrupt pulmonary vascular function and promote lingering PH.
Copyright © 2014 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24361497      PMCID: PMC3906492          DOI: 10.1016/j.ajpath.2013.10.027

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  45 in total

1.  Lack of CCR7 induces pulmonary hypertension involving perivascular leukocyte infiltration and inflammation.

Authors:  Karl-Otto Larsen; Arne Yndestad; Ivar Sjaastad; Else Marit Løberg; Ingeborg Løstegaard Goverud; Bente Halvorsen; Jing Jia; Arne K Andreassen; Cathrine Husberg; Sofia Jonasson; Martin Lipp; Geir Christensen; Pål Aukrust; Ole Henning Skjønsberg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-04-15       Impact factor: 5.464

2.  Schistosomiasis-induced experimental pulmonary hypertension: role of interleukin-13 signaling.

Authors:  Brian B Graham; Margaret M Mentink-Kane; Hazim El-Haddad; Shawn Purnell; Li Zhang; Ari Zaiman; Elizabeth F Redente; David W H Riches; Paul M Hassoun; Angela Bandeira; Hunter C Champion; Ghazwan Butrous; Thomas A Wynn; Rubin M Tuder
Journal:  Am J Pathol       Date:  2010-07-29       Impact factor: 4.307

3.  Selective expansion of polyfunctional pathogen-specific CD4(+) T cells in HIV-1-infected patients with immune reconstitution inflammatory syndrome.

Authors:  Yolanda D Mahnke; Jamieson H Greenwald; Rebecca DerSimonian; Gregg Roby; Lis R V Antonelli; Alan Sher; Mario Roederer; Irini Sereti
Journal:  Blood       Date:  2012-01-04       Impact factor: 22.113

Review 4.  Cellular and molecular mechanisms of autoimmune disease.

Authors:  Brad Bolon
Journal:  Toxicol Pathol       Date:  2011-11-21       Impact factor: 1.902

Review 5.  Inflammation, immunological reaction and role of infection in pulmonary hypertension.

Authors:  S S Pullamsetti; R Savai; W Janssen; B K Dahal; W Seeger; F Grimminger; H A Ghofrani; N Weissmann; R T Schermuly
Journal:  Clin Microbiol Infect       Date:  2011-01       Impact factor: 8.067

6.  Interferon and alternative activation of monocyte/macrophages in systemic sclerosis-associated pulmonary arterial hypertension.

Authors:  Romy B Christmann; Everett Hayes; Sarah Pendergrass; Cristina Padilla; Giuseppina Farina; Alsya J Affandi; Michael L Whitfield; Harrison W Farber; Robert Lafyatis
Journal:  Arthritis Rheum       Date:  2011-06

Review 7.  Immune reconstitution inflammatory syndrome: the trouble with immunity when you had none.

Authors:  Daniel L Barber; Bruno B Andrade; Irini Sereti; Alan Sher
Journal:  Nat Rev Microbiol       Date:  2012-01-09       Impact factor: 60.633

8.  Inhalation of Stachybotrys chartarum evokes pulmonary arterial remodeling in mice, attenuated by Rho-kinase inhibitor.

Authors:  Masaru Nagayoshi; Yuji Tada; James West; Eri Ochiai; Akira Watanabe; Takahito Toyotome; Nobuhiro Tanabe; Yuichi Takiguchi; Ayako Shigeta; Tadashi Yasuda; Kazutoshi Shibuya; Katsuhiko Kamei; Koichiro Tatsumi
Journal:  Mycopathologia       Date:  2011-04-20       Impact factor: 2.574

9.  Elevated frequencies of highly activated CD4+ T cells in HIV+ patients developing immune reconstitution inflammatory syndrome.

Authors:  Lis R V Antonelli; Yolanda Mahnke; Jessica N Hodge; Brian O Porter; Daniel L Barber; Rebecca DerSimonian; Jamieson H Greenwald; Gregg Roby; Joann Mican; Alan Sher; Mario Roederer; Irini Sereti
Journal:  Blood       Date:  2010-07-26       Impact factor: 22.113

10.  Graves' disease as immune reconstitution disease in HIV-positive patients is associated with naive and primary thymic emigrant CD4(+) T-cell recovery.

Authors:  Virginia Sheikh; Rebecca Dersimonian; Aaron G Richterman; Brian O Porter; Ven Natarajan; Peter D Burbelo; Adam Rupert; Brian H Santich; Lela Kardava; JoAnn M Mican; Susan Moir; Irini Sereti
Journal:  AIDS       Date:  2014-01-02       Impact factor: 4.177

View more
  6 in total

1.  Vascular Dysfunction in Pneumocystis-Associated Pulmonary Hypertension Is Related to Endothelin Response and Adrenomedullin Concentration.

Authors:  Dan W Siemsen; Erin Dobrinen; Soo Han; Kari Chiocchi; Nicole Meissner; Steve D Swain
Journal:  Am J Pathol       Date:  2015-12-11       Impact factor: 4.307

Review 2.  Drug abuse and HIV-related pulmonary hypertension: double hit injury.

Authors:  Zachery J Harter; Stuti Agarwal; Pranjali Dalvi; Norbert F Voelkel; Navneet K Dhillon
Journal:  AIDS       Date:  2018-11-28       Impact factor: 4.177

3.  New mouse model of pulmonary hypertension induced by respiratory syncytial virus bronchiolitis.

Authors:  Dai Kimura; Jordy Saravia; Sridhar Jaligama; Isabella McNamara; Luan D Vu; Ryan D Sullivan; Salvatore Mancarella; Dahui You; Stephania A Cormier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-06-15       Impact factor: 4.733

4.  Effector T Cells and Ischemia-Induced Systemic Angiogenesis in the Lung.

Authors:  Qiong Zhong; John Jenkins; Aigul Moldobaeva; Franco D'Alessio; Elizabeth M Wagner
Journal:  Am J Respir Cell Mol Biol       Date:  2016-03       Impact factor: 6.914

5.  Pneumocystis jirovecii in Spanish Patients With Heart Failure.

Authors:  Izarbe Merino-Casallo; Vicente Friaza; Sebastián Menao; José María Domingo; Susana Olivera; Enrique J Calderón; Miguel Ángel Torralba
Journal:  Front Public Health       Date:  2019-10-09

6.  Comparative Transcriptome Analysis Identifies CCDC80 as a Novel Gene Associated with Pulmonary Arterial Hypertension.

Authors:  Shota Sasagawa; Yuhei Nishimura; Hirofumi Sawada; Erquan Zhang; Shiko Okabe; Soichiro Murakami; Yoshifumi Ashikawa; Mizuki Yuge; Koki Kawaguchi; Reiko Kawase; Yoshihide Mitani; Kazuo Maruyama; Toshio Tanaka
Journal:  Front Pharmacol       Date:  2016-06-07       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.